Pharmaceutical Interventions for Nursing Practice
(2026-2027) UPDATE EXAM 60 QUESTIONS WITH
MULTIPLE CHOICES VERIFIED & REVISED
ANSWERS (NEW)!!
ACE inhibitors - CORRECT ANSWER: -pril
Enalapril (Vasotec), Lisinopril, Verapmil
Heart Failure
LV dysfunction
Blocks conversion of Angiotensin I > II
Decrease vasoconstriction
DRY HACKING
Monitor for tachy, angina, heart failure, NSAIDS + allopurinol
EMPTY STOMACH
Acetaminophen (Tylenol) - CORRECT ANSWER: Mild to moderate pain relief
Fever reduction
LACKS anti-inflammatory effect
DOES NOT CAUSE BLEEDING OR GI PROBLEMS
,CAN CAUSE HEPATOTOXICITY
Antidote: Acetylcysteine (Acetadote)
Adrenergic Agonists - CORRECT ANSWER: drug that stimulates adrenergic receptors of the
SNS, either directly (reacts with receptor site) or indirectly (increases NE levels) also known as
sympathomimetic bc mimics effects of SNS
Anti-epileptics in general - CORRECT ANSWER: Interventions:
Stop drugs for toxic effects
Administer with food to reduce GI upset
Monitor Labs
Wean Off to prevent seizure events
Pregnancy counseling
Medic-Alert bracelet
Cautions:
Barbs:
CNS DEP, Addiction + withdrawal
Benzos:
Pardoxical effects, watch for CNS effects when taken with alcohol or other depressors
Carbamazepine:
CNS depression, bone marrow suppression, interactions with oral contraceptives (makes not
effective)
Interact with Warfarin: may have less anticoagulation effects
, antiarrhythmic drugs - CORRECT ANSWER: Class I: sodium channel blockers (Lidocaine) for
ventricular
Class II: Beta Blockers (HTN + MI)
Class III: Potassium channel blockers (Amidorone) ventricular irritability, Vtach, Vfib
Class IV: Calcium channel blockers (Diltiazem/Cardizem) supraventricular tachy, afib, atrial
flutter
Antiplatelet drugs - CORRECT ANSWER: PROTOTYPE: ASPIRIN
Plavix, aspirin, anagrelide
FOR: CAD, maintenance of arterial/venous grafts, prevents cerebrovascular occlusion,
during/post MI for thrombolytic effect
Inhibit platelet aggregation and adhesion
ASPIRIN: inhibits synthesis of thromboxane A + decreases platelet aggregation
PLAVIX: inhibits binding of ATP (inhibits platelet aggregation)
ANAGRELIDE: blocks production of platelets in bone marrow (treats thrombocythemia)
CI: bleeding d/o, uncontrolled HTN, recent surgery
CAUTION: monitor bleeding, combo with other anticoag/antiplatelet drugs, monitor for
salicylate poisoning